Clinical Trial Update: Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating autologous bone marrow-derived stem cells in patients with Amyotrophic Lateral Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Autologous bone marrow stem cells (autologous bone marrow stem cells)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED